JOSHUA HOMME: Open Payments
NPI 1275188856 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$311 in 17 payments from 10 companies in 2025. Trend: 2023 $199 · 2024 $411 · 2025 $311
Food & beverage: $311
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $70 |
| Genentech USA, Inc. | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 2 | $31 |
| Vifor Pharma, Inc. | 1 | $21 |
| Travere Therapeutics, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Amgen Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: JARDIANCE, Kerendia, Fabhalta, Veltassa, JYNARQUE, BENLYSTA, TAVNEOS, FARXIGA.
Industry payments across NE — which companies pay providers there.
